Format

Send to

Choose Destination
Hepatology. 2018 Jan;67(1):358-380. doi: 10.1002/hep.29086.

AASLD guidelines for the treatment of hepatocellular carcinoma.

Author information

1
Division of Transplant Surgery, William J. von Liebig Transplant Center, Mayo Clinic, Rochester, MN.
2
Department of Medicine, Division of Gastroenterology and Hepatology, Northwestern University, Chicago, IL.
3
Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at the University of California, Los Angeles, Santa Monica Geffen School of Medicine at UCLA, Los Angeles, California.
4
Liver Imaging Group, Department of Radiology, University of California, San Diego.
5
Northwestern University Feinberg School of Medicine, Chicago, IL.
6
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
7
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
8
Mayo Clinic Evidence-based Practice Center, Mayo Clinic, Rochester, MN.
9
Digestive and Liver Diseases Division, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX.
PMID:
28130846
DOI:
10.1002/hep.29086
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center